Status
Conditions
Treatments
About
Blood flow restricted (BFR) exercise has been shown to improve skeletal muscle adaptations to resistance exercise. BFR uses blood pressure cuffs (i.e., tourniquets) to reduce skeletal muscle blood flow during resistance exercise. One benefit of BFR is that skeletal muscle adaptations to resistance exercise training including muscle hypertrophy and increases in strength can be achieved at lower-loads (e.g., 25-30% 1RM), that are often comparable to more traditional resistance training loads (70-85% 1RM). However, the impact that low-load BFR resistance exercise has on muscle quality and bioenergetics is unknown. The present study will examine the impact of 6 weeks of low-load, single-leg resistance exercise training with or without personalized BFR on measures of muscle mass, strength, quality, and mitochondrial bioenergetics. The investigators will recruit and study up to 30, previously sedentary, healthy, college-aged adults (18-40 years). The investigators will measure muscle mass using Dual Energy X-Ray Absorptiometry and muscle strength and endurance using isokinetic testing. The investigators will normalize knee extensor strength to lower limb lean mass to quantify muscle quality. The investigators will also use near infrared spectroscopy (NIRS) to measure mitochondrial oxidative capacity in the vastus lateralis. Finally, the investigators will measure markers of systemic inflammation and markers of muscle damage using commercially available ELISA assays.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria.
Exclusion Criteria.
Evidence or self-report being pregnant, lactating, or anticipating becoming pregnant in the next year
Participation in resistance or aerobic exercise training > 2 days per week within the 3 months prior to screening
Self-report of history of type 1 or 2 diabetes mellitus
Self-report history of cardiovascular, peripheral vascular, cerebral vascular, pulmonary, or renal disease
Self-report or evidence of uncontrolled hypertension
Self-report history of blood clotting disorders
Self-report history of deep vein thrombosis or pulmonary embolism
Self-report history of sickle cell trait
Self-report history of varicose veins
Self-report history of a myopathy leading to muscle loss, weakness, severe cramps or myalgia
Self-report history of orthopedic limitations that would preclude them from participation in a dynamic exercise program
Self-report history of musculoskeletal disorders (e.g., severe osteoarthritis, rheumatoid arthritis, avascular necrosis or osteonecrosis)
Self-report history of neurological disorders (e.g., peripheral neuropathy, amyotrophic lateral sclerosis, multiple sclerosis, fibromyalgia, Parkinson's disease)
Weight loss of > 10% in the last 3 months prior to screening
Active smoking
Current consumption of > 14 alcoholic drinks per week based on self-report
Absolute Contraindication to Exercise as Defined by the American College of Sports Medicine,1 including:
Self-report acute viral or bacterial upper or lower respiratory infection at screening
Any other condition that in the judgement of the Principal Investigator and/or the Medical Director of this protocol may interfere with study participation and adherence to the protocol
Primary purpose
Allocation
Interventional model
Masking
24 participants in 2 patient groups
Loading...
Central trial contact
Brian Irving, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal